Esig, Narisa N.

HRN: 23-90-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFTRIAXONE 1G (VIAL)
10/17/2023
10/23/2023
IV
2g
OD
Infectious Diarrhea
Waiting Final Action 
10/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2023
10/23/2023
IV
500MG
Q8
Infectious Diarrhea
Waiting Final Action 
10/17/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/17/2023
10/17/2023
IV
4.5
Now Only
Sepsis
Waiting Final Action 
10/17/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/17/2023
10/23/2023
IV
2.25
Q6
Sepsis; AGE With Severe Dehydration
Waiting Final Action 
10/19/2023
CEFTRIAXONE 1G (VIAL)
10/19/2023
10/25/2023
IV
2gm
OD
Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: